Health · 10 June 2026

Scientists find why Ozempic fails for some people

Researchers have identified genetic variants that appear to make some people far less responsive to GLP-1 drugs such as Ozempic and Mounjaro. Roughly 10% of the population carries these variants, which seem to cause a form of GLP-1 resistance that blunts the medication's effect. The finding could help doctors predict who will benefit from the drugs before prescribing them.

By BriefTea Editorial · 10 June 2026 at 13:01

Reported by ScienceDaily · How we write briefs

Get the app

More briefs

HealthMan changes life after doctor warns liver disease could kill him HealthSweetener used in chewing gum and jam linked to strokes and heart attacks HealthMouth cancer rates up a third in UK, often with no obvious cause HealthBox breathing helps calm stress and reduce anxiety, say experts HealthNHS managers warn spiralling costs could disrupt ADHD and autism care HealthThousands of UK women get undiagnosed PTSD after childbirth More health stories → Browse all stories →